DURECT (DRRX): Bathi resik saben saham sajrone 12 wulan pungkasan

Simbol lan logo merek DURECT Corporation (DRRX)

DURECT Corporation focuses on epigenetics, utilizing the proprietary DUR-928 for liver cell restoration. This rolling annual EPS chart provided by GURU.Markets demonstrates profit dynamics, where the current level is approximately -0.47. The business model relies on outsourced manufacturing, and its independence from macroeconomic factors makes the asset a resilient defensive tool during recessionary periods.

DRRX (DURECT Corporation) riwayat Bathi resik saben siji saham sajrone rolas wulan pungkasan saka 04.07.2022 nganti 27.09.2025

Rincian metrik keuangan lan pasar durect.com (DRRX)

- rega saham lan target rega konsensus:
Analisis kabeh metrik perusahaan:DRRX - DURECT Corp.
Produk sing diprodhuksi DURECT Corporation

The specifics of the biotechnology sector for DURECT Corporation (DRRX) entail high R&D expenses coupled with a deficit of operating income. This metric is calculated as the ratio of total annual net income to the number of shares outstanding. It measures the actual efficiency of capital allocation and the business's ability to generate value. The negative trend in the company's net income per share over 12 months confirms a stage of burning through reserves. Analysis of this chart allows for an assessment of the rate of capital depletion.